机构:[1]The People's Hospital of ChuXiong Yi Autonomous Prefecture, ChuXiong, China.[2]School of Pharmaceutical Sciences & Yunnan Key Laboratory of Pharmacology for Natural Products, College of Modern Biomedical Industry, Kunming Medical University, Kunming, China.[3]Department of Pathology, the First Affiliated Hospital of Kunming Medical University, Kunming, China.医技科室病理科昆明医科大学附属第一医院
National Natural Science Foundation of China (No.
82260727),Yunnan Provincial Science and Technology Department (No.202101AY070001-010), and the Innovation Team Construction Project of Kunming Medical University(CXTD202203).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
无
最新[2023]版:
大类|3 区综合性期刊
小类|3 区综合性期刊
第一作者:
第一作者机构:[1]The People's Hospital of ChuXiong Yi Autonomous Prefecture, ChuXiong, China.[2]School of Pharmaceutical Sciences & Yunnan Key Laboratory of Pharmacology for Natural Products, College of Modern Biomedical Industry, Kunming Medical University, Kunming, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yin Jian-Bin,Wang Ying-Xia,Fan Su-Su,et al.Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways[J].Plos One.2024,19(9):e0309833.doi:10.1371/journal.pone.0309833.
APA:
Yin Jian-Bin,Wang Ying-Xia,Fan Su-Su,Shang Wen-Bin,Zhu Yu-Shan...&Zhang Xuan.(2024).Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways.Plos One,19,(9)
MLA:
Yin Jian-Bin,et al."Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways".Plos One 19..9(2024):e0309833